In the afternoon of the 11th of January, a large group of Chinese PhD candidates and some of their supervisors came together with our dean Prof Pancras Hogendoorn, LUMC Global, the Graduate School and LAP in the HePatho Bar to celebrate the western new year and formally meet each other. We also looked forward to the celebration of the Chinese new year, the year of the rabbit!
It was truly heartwarming to see this group of ambitious young researchers together, who are spread over many different departments and research groups within the LUMC. We exchanged experiences and answered questions, but most of all, we had a blast connecting socially! We are looking forward to follow the exciting academic journey of our new arrivals.
The Leiden University Medical Center (LUMC) and Ixaka Ltd. have announced a research collaboration on 30 March 2021, to better understand REX-001, Ixaka’s lead cell therapy product. The project will be led by Professor Paul Quax, Head of Experimental Vascular Surgery at the LUMC, to support accelerated development of REX-001 in Phase III clinical trials for the treatment of chronic limb-threatening ischemia (CLTI).
Global epidemics come in many forms and attract different kinds of attention depending on the severity of the diseases. But as Fathimah’s research demonstrates, there’s a risk that comes with giving too little attention to epidemics that don’t have immediate life altering/threatening effects. It’s for this exact reason that obesity is often overlooked in terms of severity. In the short term, obesity isn’t life threatening perse, but over time, the complications of obesity become progressively more dangerous and ultimately life threatening. With around 40 percent of the global population being overweight and 13 percent suffering from obesity, Fathimah’s recent PhD research on the topic might prove invaluable in the future.
By developing an improved health data management system, the Virus Outbreak Data Network (VODAN)-Africa research team is enabling local and global distributed access to crucial data required to fight the COVID-19 pandemic, future disease outbreaks and general disease conditions.